CN106187818A - 一种制备抗癌药物伏立诺他的方法 - Google Patents
一种制备抗癌药物伏立诺他的方法 Download PDFInfo
- Publication number
- CN106187818A CN106187818A CN201610486758.XA CN201610486758A CN106187818A CN 106187818 A CN106187818 A CN 106187818A CN 201610486758 A CN201610486758 A CN 201610486758A CN 106187818 A CN106187818 A CN 106187818A
- Authority
- CN
- China
- Prior art keywords
- suberic acid
- vorinostat
- substrate
- self
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WAEXFXRVDQXREF-UHFFFAOYSA-N vorinostat Chemical compound ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1 WAEXFXRVDQXREF-UHFFFAOYSA-N 0.000 title claims abstract description 39
- 229960000237 vorinostat Drugs 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims abstract description 37
- 239000003814 drug Substances 0.000 title claims abstract description 6
- 229940079593 drug Drugs 0.000 title claims abstract description 5
- 238000011275 oncology therapy Methods 0.000 title claims abstract description 5
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 claims abstract description 111
- 239000000758 substrate Substances 0.000 claims abstract description 42
- 238000006243 chemical reaction Methods 0.000 claims abstract description 32
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims abstract description 29
- 150000003931 anilides Chemical class 0.000 claims abstract description 16
- 238000001338 self-assembly Methods 0.000 claims abstract description 11
- 238000003756 stirring Methods 0.000 claims abstract description 9
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical class C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000002027 dichloromethane extract Substances 0.000 claims abstract description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 39
- 239000000243 solution Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000008367 deionised water Substances 0.000 claims description 10
- 229910021641 deionized water Inorganic materials 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 8
- 239000005357 flat glass Substances 0.000 claims description 6
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- 229910017604 nitric acid Inorganic materials 0.000 claims description 5
- 229910052710 silicon Inorganic materials 0.000 claims description 5
- 239000010703 silicon Substances 0.000 claims description 5
- 238000009413 insulation Methods 0.000 claims description 3
- 239000010453 quartz Substances 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 11
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 10
- 230000004044 response Effects 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 229960003424 phenylacetic acid Drugs 0.000 description 5
- 239000003279 phenylacetic acid Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000007822 coupling agent Substances 0.000 description 4
- -1 suberic acid acid anhydride Chemical class 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- NZRWECQCBREPPG-UHFFFAOYSA-N 8-amino-8-oxooctanoic acid Chemical class NC(=O)CCCCCCC(O)=O NZRWECQCBREPPG-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- CMQCNTNASCDNGR-UHFFFAOYSA-N toluene;hydrate Chemical compound O.CC1=CC=CC=C1 CMQCNTNASCDNGR-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610486758.XA CN106187818B (zh) | 2016-06-27 | 2016-06-27 | 一种制备抗癌药物伏立诺他的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610486758.XA CN106187818B (zh) | 2016-06-27 | 2016-06-27 | 一种制备抗癌药物伏立诺他的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106187818A true CN106187818A (zh) | 2016-12-07 |
CN106187818B CN106187818B (zh) | 2017-12-08 |
Family
ID=57461950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610486758.XA Expired - Fee Related CN106187818B (zh) | 2016-06-27 | 2016-06-27 | 一种制备抗癌药物伏立诺他的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106187818B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109096148A (zh) * | 2018-10-16 | 2018-12-28 | 陈国妃 | 利用改性介孔材料一锅法制备伏立诺他的方法 |
CN109134313A (zh) * | 2018-10-16 | 2019-01-04 | 陈国妃 | 一种利用改性介孔材料催化制备伏立诺他的方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1541549A1 (en) * | 2003-12-12 | 2005-06-15 | Exonhit Therapeutics S.A. | Tricyclic hydroxamate and benzaminde derivatives, compositions and methods |
CN1720034A (zh) * | 2002-03-04 | 2006-01-11 | 艾顿药物公司 | 诱导末期分化的方法 |
CN300809589S (zh) * | 2007-07-12 | 2008-07-30 | 安阳市万通机械有限公司 | 路面清扫机 |
CN102264694A (zh) * | 2008-10-15 | 2011-11-30 | 基因里克斯(英国)有限公司 | 用于制备伏立诺他的方法 |
CN104292133A (zh) * | 2014-09-29 | 2015-01-21 | 崔银方 | 一种抗癌药物伏立诺他的合成方法 |
-
2016
- 2016-06-27 CN CN201610486758.XA patent/CN106187818B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1720034A (zh) * | 2002-03-04 | 2006-01-11 | 艾顿药物公司 | 诱导末期分化的方法 |
EP1541549A1 (en) * | 2003-12-12 | 2005-06-15 | Exonhit Therapeutics S.A. | Tricyclic hydroxamate and benzaminde derivatives, compositions and methods |
CN300809589S (zh) * | 2007-07-12 | 2008-07-30 | 安阳市万通机械有限公司 | 路面清扫机 |
CN102264694A (zh) * | 2008-10-15 | 2011-11-30 | 基因里克斯(英国)有限公司 | 用于制备伏立诺他的方法 |
CN104292133A (zh) * | 2014-09-29 | 2015-01-21 | 崔银方 | 一种抗癌药物伏立诺他的合成方法 |
Non-Patent Citations (2)
Title |
---|
周忻: "组蛋白去乙酰化酶抑制剂SAHA的合成研究", 《海南医学院学报》 * |
高博 等: "芘丁酸在玻璃基片表面的单层自组装", 《功能材料》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109096148A (zh) * | 2018-10-16 | 2018-12-28 | 陈国妃 | 利用改性介孔材料一锅法制备伏立诺他的方法 |
CN109134313A (zh) * | 2018-10-16 | 2019-01-04 | 陈国妃 | 一种利用改性介孔材料催化制备伏立诺他的方法 |
CN109096148B (zh) * | 2018-10-16 | 2021-04-20 | 新昌县勤勉生物医药科技有限公司 | 利用改性介孔材料一锅法制备伏立诺他的方法 |
CN109134313B (zh) * | 2018-10-16 | 2021-05-25 | 新昌县勤勉生物医药科技有限公司 | 一种利用改性介孔材料催化制备伏立诺他的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106187818B (zh) | 2017-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101798270B (zh) | 一种3-氨基-1-金刚烷醇的制备方法 | |
CN103664912B (zh) | 一种普卡必利的合成工艺 | |
CN106349245A (zh) | 一种磷酸西格列汀杂质及其制备方法和用途 | |
CN103304512A (zh) | 一种非布索坦的制备方法 | |
CN102115486B (zh) | 一种3-β-花生酰胺基-7α,12α,5β-胆烷-24-羧酸的制备方法 | |
CN108558747A (zh) | 一种瑞戈非尼的制备方法 | |
CN102786431A (zh) | 一种盐酸丙帕他莫的制备方法 | |
CN106187818B (zh) | 一种制备抗癌药物伏立诺他的方法 | |
CN109867673B (zh) | 一种合成帕布昔利布的方法 | |
CN101624351A (zh) | 一种dl-赖氨酸的制备方法 | |
CN102351790B (zh) | 7-溴-6-氯-4(3h)-喹诺酮的合成方法 | |
CN108726569A (zh) | 一种六氟锑酸银的制备方法 | |
CN106008267B (zh) | 一种抗癌药物伏立诺他的制备方法 | |
CN104592122A (zh) | 3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺的制备方法 | |
CN108997209A (zh) | 一种瑞戈非尼的制备方法 | |
CN114736154A (zh) | N-(3-氯-4-(2-吡啶甲氧基)苯基)-2-氰基乙酰胺的制备方法 | |
CN102942521B (zh) | 罗氟司特的制备方法 | |
CN104292133A (zh) | 一种抗癌药物伏立诺他的合成方法 | |
CN112940022A (zh) | 一种二甲胺硼烷的制备方法 | |
CN105777582B (zh) | 一种制备抗癌药物伏立诺他的方法 | |
CN110156805B (zh) | 一种2, 3-二氢-1, 4-二氧代[2,3-b]吡啶-7-羧酸的制备方法 | |
CN112174966B (zh) | 一种制备盐酸吡西卡尼的新方法 | |
CN107778160A (zh) | 一种3,4,5,6‑四氟邻苯二甲酸的制备方法 | |
CN105837635A (zh) | 一种用于治疗骨质疏松的米诺膦酸的制备方法 | |
JPS6183168A (ja) | 2−メルカプト−4−アミノ−5−ホルミルピリミジンおよびその製法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Meixin Inventor after: Lv Yingpin Inventor before: Wang Chuanxiu |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171114 Address after: 266003 Shandong city of Qingdao province Jiangsu City Road 16, the Affiliated Hospital of Qiingdao University Applicant after: Liu Meixin Applicant after: Lv Yingpin Address before: 266109 Shandong, Qingdao, Chengyang District, No. 825 Zhengyang Road, building, room 1, office, room 205 Applicant before: The skies, Qingdao Bioisystech Co., Ltd |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181225 Address after: 266003 Affiliated Hospital of Qiingdao University, 16 Jiangsu Road, Shinan District, Qingdao, Shandong Patentee after: Affiliated Hospital of University Of Qingdao Address before: 266003 Affiliated Hospital of Qiingdao University, 16 Jiangsu Road, Shinan District, Qingdao, Shandong Co-patentee before: Lv Yingpin Patentee before: Liu Meixin |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171208 Termination date: 20190627 |